304 related articles for article (PubMed ID: 32756358)
1. Ion Channels as Therapeutic Targets for Viral Infections: Further Discoveries and Future Perspectives.
Charlton FW; Pearson HM; Hover S; Lippiat JD; Fontana J; Barr JN; Mankouri J
Viruses; 2020 Aug; 12(8):. PubMed ID: 32756358
[TBL] [Abstract][Full Text] [Related]
2. Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication.
Russell T; Gangotia D; Barry G
Biomed Pharmacother; 2022 Dec; 156():113850. PubMed ID: 36411658
[TBL] [Abstract][Full Text] [Related]
3. Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.
Pietschmann T
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807238
[TBL] [Abstract][Full Text] [Related]
4. Viral dependence on cellular ion channels - an emerging anti-viral target?
Hover S; Foster B; Barr JN; Mankouri J
J Gen Virol; 2017 Mar; 98(3):345-351. PubMed ID: 28113044
[TBL] [Abstract][Full Text] [Related]
5. Host Calcium Channels and Pumps in Viral Infections.
Chen X; Cao R; Zhong W
Cells; 2019 Dec; 9(1):. PubMed ID: 31905994
[TBL] [Abstract][Full Text] [Related]
6. The skeletal muscle channelopathies: distinct entities and overlapping syndromes.
Davies NP; Hanna MG
Curr Opin Neurol; 2003 Oct; 16(5):559-68. PubMed ID: 14501839
[TBL] [Abstract][Full Text] [Related]
7. Ion channels in presynaptic nerve terminals and control of transmitter release.
Meir A; Ginsburg S; Butkevich A; Kachalsky SG; Kaiserman I; Ahdut R; Demirgoren S; Rahamimoff R
Physiol Rev; 1999 Jul; 79(3):1019-88. PubMed ID: 10390521
[TBL] [Abstract][Full Text] [Related]
8. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
Thorneloe KS
IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
11. [Mitochondrial ion channels].
Skalska J; Debska-Vielhaber G; Głab M; Kulawiak B; Malińska D; Koszela-Piotrowska I; Bednarczyk P; Dołowy K; Szewczyk A
Postepy Biochem; 2006; 52(2):137-44. PubMed ID: 17078503
[TBL] [Abstract][Full Text] [Related]
12. [Ion channels and epilepsy].
Armijo JA; de las Cuevas I; Adín J
Rev Neurol; 2000 Jun; 30 Suppl 1():S25-41. PubMed ID: 10904966
[TBL] [Abstract][Full Text] [Related]
13. [Channels: a new way to revisit pathology].
Fournier E
Bull Acad Natl Med; 2014 Feb; 198(2):225-41; discussion 241-2. PubMed ID: 26263701
[TBL] [Abstract][Full Text] [Related]
14. Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication.
Premkumar A; Dong X; Haqshenas G; Gage PW; Gowans EJ
Antivir Ther; 2006; 11(3):289-95. PubMed ID: 16759044
[TBL] [Abstract][Full Text] [Related]
15. Ion channel modulators and urinary tract function.
Brading AF; Brain KL
Handb Exp Pharmacol; 2011; (202):375-93. PubMed ID: 21290236
[TBL] [Abstract][Full Text] [Related]
16. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ; Sasadeusz JJ; Tannock GA
Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
[TBL] [Abstract][Full Text] [Related]
17. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
Mercorelli B; Palù G; Loregian A
Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of cationic amphiphilic drugs.
Salata C; Calistri A; Parolin C; Baritussio A; Palù G
Expert Rev Anti Infect Ther; 2017 May; 15(5):483-492. PubMed ID: 28286997
[TBL] [Abstract][Full Text] [Related]
19. Repurposing host-based therapeutics to control coronavirus and influenza virus.
Li CC; Wang XJ; Wang HR
Drug Discov Today; 2019 Mar; 24(3):726-736. PubMed ID: 30711575
[TBL] [Abstract][Full Text] [Related]
20. Ion channels as antivirus targets.
Liang X; Li ZY
Virol Sin; 2010 Aug; 25(4):267-80. PubMed ID: 20960300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
